Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS registry
AH Schmidt, J Sauter, J Schetelig, E Neujahr… - Best Practice & …, 2024 - Elsevier
Allogeneic hematopoietic stem cell (HSC) transplantation is a curative therapy for many
severe blood diseases. As many patients have no suitable family donor, large unrelated …
severe blood diseases. As many patients have no suitable family donor, large unrelated …
High population frequencies of MICA copy number variations originate from independent recombination events
A Klussmeier, K Putke, S Klasberg, M Kohler… - Frontiers in …, 2023 - frontiersin.org
MICA is a stress-induced ligand of the NKG2D receptor that stimulates NK and T cell
responses and was identified as a key determinant of anti-tumor immunity. The MICA gene …
responses and was identified as a key determinant of anti-tumor immunity. The MICA gene …
5 years DKMS Chile: approach, results and impact of the first unrelated stem cell donor center in Chile
F Barriga, UV Solloch, A Giani, J Palma… - Frontiers in …, 2023 - frontiersin.org
Introduction Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is performed
worldwide to treat blood cancer and other life-threatening blood disorders. As successful …
worldwide to treat blood cancer and other life-threatening blood disorders. As successful …
Optimisation of global stem cell donor recruitment based on analysis of unsuccessful donor searches
Despite over 41 million registered potential volunteer stem cell donors worldwide, many
patients in need of a transplant do not find an HLA‐matched unrelated donor or cord blood …
patients in need of a transplant do not find an HLA‐matched unrelated donor or cord blood …